Bacterial resistance: origins, epidemiology, and impact.

By D. Livermore. Clinical Infectious Diseases, 2003

643 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/9f79e4e537d6ab47627af040175ef060f65b621a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

1. P. Bradford
2. K. Bush
3. W. Reygaert

In Molecular Medicine

1. James J. Collins
2. P. Bradford
3. K. Bush
4. M. Tomás
5. G. Bou
6. A. Beceiro
7. W. Reygaert
8. P. Nordmann

In Pharmacology

1. James J. Collins
2. P. Bradford
3. K. Bush

Citations in the corpus

• Isolation of soil Streptomyces as source antibiotics active against antibiotic-resistant bacteria (2008, background): “Rising numbers of antibioticunresponsive infectious disease agents confront patients worldwide (Levy 2002, Livermore 2003 ) and consensus has emerged that it is essential that novel antibiotic classes be developed as part of the strategy to control the emerging drug-resistant pathogens (Projan 2002”
• Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? (2013, background): “Moreover, strains that are poorly adapted or poor colonizers of new niches, but which are resistant, are now more likely to replace those well-adapted or colonizing species that are more susceptible to the presence of antibiotics (418).”
• A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance (2014, neutral): “isation and premature mortality [2-4].”
• Sub-lethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis (2010, background): “There are a number of mechanisms whereby bacteria can develop antibiotic resistance (Dwyer et al., 2009; Hegreness et al., 2008; Livermore, 2003; McKenzie and Rosenberg, 2001), including horizontal transfer of resistance genes (Davies, 1994), drug-specific selection of naturally occurring resistant…”
• Epidemiology of β-Lactamase-Producing Pathogens (2020, background): “When resistant mutants emerge that are still able to replicate and cause disease, they can gain a foothold in the population that is maintained by continued use of that antibiotic (61).”